Meaning 

---

The 10th Annual Global Discovery To Development Innovation Forum (GDDIF) is the leading pharmaceutical R&D Summit for pharma decision makers, scientific leaders, and solutions experts. 
​This series brings together prominent leaders from both industry and academia to mindshare, benchmark and exchange cutting-edge innovation to manage, strategize and integrate new paradigms to surpass and transcend the quality of drug discovery, biology, and development.
Taking a truly integrated approach to drug discovery. The 10th Annual GDDIF is dedicated to scientific insights, technology innovation & strategy across areas such as medicinal chemistry, in vitro and in vivo biology, structural biology, and computer-aided drug design etc.

Themes

• Innovation within Screening, Enabling Technologies and Collaborative Partnerships.
• ​CRISPR-Cas and iPSC technologies for drug discovery.
• How PBPK modelling has evolved in the last decade
  
• PK-PD strategies implemented in early drug discovery
  
• How physical properties influence ADME-Tox compound progression
  
• The use of in-house ADME prediction tools in design
  
• Physiologically based pharmacokinetic modelling
  
• Understanding how to use in vitro data
  
• Single Cell Analysis. 
• Small Molecule Medicinal Chemistry: Strategies and Technologies​
• Enabling Collaborative Data Analysis
• Improving R&D Productivity & Data Quality
• Open-Access Collaboration in Accelerating Early Stage Drug Discovery
• How to Attract Potential Licensing Partners in Early Drug Discovery
• soloMER™ Biologics: Next-Generation Therapeutics for the Site-Specific Treatment of Inflammatory Disease
• Overcoming limitations of antibodies using engineered Affimer binding proteins

Testimonials

Annual www.bioinnovationasia.com
​ Leaders Innovation Summit 2017

Audience

---

Join Up To 150 Leaders & Attend The Exclusive GDDIF - The Original Innovation Summit. Job Titles Will Include 

• SVP R&D 
• Heads Of R&D

• Informatics
• Medicinal Chemistry
• Heads of ADME & DMPK
• Heads Of Discovery
• Principal Scientists
• Head Of External Collaborations
• Heads of Toxicology
• Lab Managers
• Heads Of Pre Clinical
• Personalised Medicine

Stream Talks

• Strategies for Developing 3D Cell Culture Assays
• Screening Natural Product-Based Compounds for Efficient Drug Discovery
• Insight into The New Era of Structure-Based Drug Design GPCRs
• Integrated Innovation in medicinal chemistry: what are the new technologies?

• Innovation in Medicinal Chemistry: what are the new technologies?

• Culture Assays for Use in Drug Discovery 

• Target Deconvolution Strategies in Novel Natural Compounds, Phenotypic Screening, Combined Screening 

• Evolution of Advance Natural Compounds and Potent Innovation in ADC’s 

• Sourcing and Designing More Physiologically.
• The role of Open Innovation for Therapeutic Medicines

• The latest in big R&D data solutions Novel therapies in companion diagnostics 

• Relevant Cellular Assays for Implementation in HTS Programmes 

• Overcoming Patient Variability | App of Genome Editing 

• Image Analysis and Data Collection, Literature Storage and Interpretation 

• Open-Access Collaboration in Accelerating Early Stage Drug Discovery 

Speakers

---

Steve Rees - AstraZeneca

Chas Bountra - University of Oxford

Stevan Djuric - AbbVie

Caroline Barelle - Elasmogen

Rolf Gueller -Chemspeed Technologies AG

Teodor Aastrup - Attana

Platinum Spotlight

Event Partners

Conversation

Tweets by DrugDiscoveryIX